A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer
Condition(s):Non-small Cell Lung Cancer Stage IIILast Updated:June 10, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer Stage IIILast Updated:June 10, 2022Not yet recruiting
Condition(s):ThrombocytopeniaLast Updated:April 29, 2022Completed
Condition(s):Malignant Neoplasms of Digestive OrgansLast Updated:March 3, 2021Not yet recruiting
Condition(s):Ovarian CancerLast Updated:May 10, 2023Recruiting
Condition(s):Colorectal NeoplasmsLast Updated:April 22, 2016Unknown status
Condition(s):Cervical Cancer; Locally Advanced Cervical Cancer; Concurrent Chemoradiotherapy; Neoadjuvant ChemoimmunotherapyLast Updated:March 1, 2024Not yet recruiting
Condition(s):Cervical Cancer; Locally Advanced Cervical Cancer; PD-L1 Negative; Neoadjuvant ChemoimmunotherapyLast Updated:March 1, 2024Not yet recruiting
Condition(s):Unknown Primary Tumors; DNA MethylationLast Updated:November 21, 2023Recruiting
Condition(s):Cervical CancerLast Updated:September 7, 2023Recruiting
Condition(s):Ovarian Clear Cell CarcinomaLast Updated:February 26, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.